Advanced company searchLink opens in new window

GLAXOCHEM (UK) UNLIMITED

Company number 04299472

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
20 May 2021 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/20
10 Nov 2020 TM01 Termination of appointment of Ciara Martha Lynch as a director on 9 November 2020
21 Sep 2020 AP01 Appointment of Mr Alistair Robert Davidson as a director on 17 September 2020
17 Sep 2020 CS01 Confirmation statement made on 28 August 2020 with updates
24 Jun 2020 AA Total exemption full accounts made up to 31 December 2019
01 Jun 2020 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/19
18 Mar 2020 TM01 Termination of appointment of Charalampos Panagiotidis as a director on 2 March 2020
18 Mar 2020 AP01 Appointment of Mrs Ciara Martha Lynch as a director on 2 March 2020
20 Feb 2020 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/19
20 Feb 2020 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/19
11 Sep 2019 AA Full accounts made up to 31 December 2018
30 Aug 2019 PSC05 Change of details for Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019
29 Aug 2019 PSC07 Cessation of Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019
28 Aug 2019 CS01 Confirmation statement made on 28 August 2019 with updates
02 Aug 2019 AP01 Appointment of Mr Charalampos Panagiotidis as a director on 31 July 2019
07 Jul 2019 CS01 Confirmation statement made on 23 June 2019 with no updates
07 May 2019 TM01 Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019
31 Jul 2018 CS01 Confirmation statement made on 23 June 2018 with no updates
10 Jul 2018 AA Full accounts made up to 31 December 2017
06 Mar 2018 PSC05 Change of details for Glaxosmithkline Sl Lp as a person with significant control on 23 June 2017
06 Mar 2018 PSC09 Withdrawal of a person with significant control statement on 6 March 2018
14 Aug 2017 AA Full accounts made up to 31 December 2016
25 Jun 2017 CS01 Confirmation statement made on 23 June 2017 with updates
18 Oct 2016 CS01 Confirmation statement made on 4 October 2016 with updates
  • ANNOTATION Clarification a second filed CS01 (Capital and Shareholders) was filed on 14/09/24
17 Jun 2016 AA Full accounts made up to 31 December 2015